Huntsman Cancer Institute at the University of Utah Selected to Join National Cancer Institute’s Systems Biology Consortium

"Our research team will study resistant breast and ovarian cancer states using systems biology in order to identify treatment strategies for these refractory tumors," said Andrea Bild, PhD, principal investigator at HCI’s CSBC and associate professor of pharmacology and toxicology at U of U Health.

Huntsman Cancer Institute (HCI) and the College of Pharmacy at University of Utah Health (U of U Health) have been awarded a $9.1 million, five-year grant from the National Cancer Institute (NCI) to serve as a Research Center in NCI’s Cancer Systems Biology Consortium (CSBC). HCI is one of nine research institutions nationwide to be selected as a Research Center in the CSBC.